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ABSTRACT
Background:
Presently, the region that disproportionally carries the highest burden of the HIV1 and HSV2
epidemic is SSA (sub-Saharan Africa). Uganda, a country in Sub-Saharan Africa, Uganda has
both high incidence of HIV1 and high prevalence of HSV2 infection. Recent statistics
demonstrate a 22% increase in HIV1 incidence from 2001 to 2011 in Uganda. A segment of this
population in Uganda is composed of female sex workers (FSWs) who in Uganda account for 35
percent of the nation's HIV1 prevalence. This study explores a population of male partners and
clients of these female sex workers (MPCSWs) in order to identify potential risk factors that this
segment of the sex work population may contribute to HIV1 and HSV2 prevalence in the sex
work population in Kampala, Uganda.
Methods:
Data was obtained from the 2008/2009 Crane Survey and collection of clinical data was
completed with the collaboration of Uganda Ministry of Health STD/AIDS Control Programme,
Makerere University School of Public Health, and the Centers for Disease Control and
Prevention. Four multiple logistic regression models were built with the ten chosen independent
variables to identify associations among these variables and each of the four cross-classified
serostatuses of HIV1 and HSV2. The level of significance of all analyses was α=.05.
Results:
Having a presence of a genital ulcer/sore in the last 12 months was found to have significant
association with cross-classified serostatuses HIV1-, HSV2- (OR: 0.52) and HIV1+, HSV2+
(OR: 2.29). Reporting "ever been married" was found to have significant association with crossclassified serostatuses HIV1-, HSV2- (OR: 0.52), HIV1+, HSV2- (OR: 2.90). The variable
"age" was found to have significance with cross-classified serostatuses HIV1-,HSV2- (OR:
0.90), HIV1-, HSV2+ (OR: 1.06), and HIV1+, HSV2+ (OR: 1.08). Lastly, those that reported
having had a circumcision had significant associations with cross-classified serostatuses HIV1+,
HSV2- (OR: 0.26) and HIV1+, HSV2+ (OR: 0.48).
Conclusion:
Although significant associations were not established across all cross-classified serostatuses for
all variables found to have at least one significant association with a cross-classified serostatus,
previous evidence provides support for these type of observational studies with similar survey
structures to have compromised statistical power and possibly explain for why within significant
variables, significant associations were not found across all outcome groups. Circumcision status
and the presence of a genital ulcer/sore in the last 12 months appears to have possible important
implications with acquiring both these infections, especially HIV-1 for the studied population.
1

CHAPTER I
Introduction
1.1 Background
HIV1 (Human Immunodeficiency Virus 1) still remains a global challenge. HIV1 is
found worldwide and it affects about 35.3 million individuals currently.71 Presently, the region
that disproportionally carries the highest burden of the HIV1 epidemic is SSA (sub-Saharan
Africa) where it is home to 70% of new HIV1 infections and where 25 million individuals live
with HIV1 according to recent statistics71. Another sexual transmitted infection that has been
documented to have high prevalence is HSV2 (Herpes Simplex Virus type-2) infection in SSA
for both the general and high risk populations.10,13,24,26,42,45,55,59,77 HSV2 is recognized as a major
cause of genital ulcerative disease where HIV1 susceptibility increases through the disruption of
the mucosal barrier associated with ulceration, and genital shedding which causes increases in
HIV1 infectivity.13,26,36,39,43,51,66 Worldwide, HSV2 has been found to be associated with HIV1
infection.13,26,36,39,43,51,66 From the documented literature, HSV2 serostatus is an important factor
and may play a role in the spread of HIV1 infection.
Uganda has both high incidence of HIV1 and high prevalence of HSV2 infection. Recent
statistics demonstrate a 22% increase in HIV1 incidence from 2001 to 2011 in Uganda.28 "A
study conducted among women from Zimbabwe and Uganda found that seroprevalence of HSV2
upon enrollment was 52% for Ugandan women in the study.7 " The population attributable risk
for HIV1 due to HSV2 infection was 42% among these Ugandan women.7 A recent study
conducted in Rakai, Uganda involved 176 men coinfected with HIV and HSV2 who underwent
male circumcision in the study and HSV2 shedding was recorded weekly until male circumcision
2

wounds were certified to be cured.23 Lavage samples were taken to record HSV2 shedding.
Lavage samples before male circumcision procedures were done before any post circumcision
lavage samples to serve as baseline for all men in this study. The study found that before male
circumcision procedures, HSV2 shedding was detected in 9.7% of men and after male
circumcision procedures HSV2 shedding was detected in 27.3% of men.24 The median time for
men to heal completely from circumcision wounds was 4 weeks. All men healed from
circumcision wounds completely by 6 weeks. Although only 15 men in the study resumed sexual
intercourse by week 4, 12 of them did not have a completely healed wound before resuming
sexual intercourse.23 This study demonstrated that men in Uganda, specifically in Rakai, may
participate in risky sexual behavior before complete wound healing where HSV2 shedding
showed in this study to have a tendency to increase, and therefore, possibly increase chances for
HSV2 transmission. The study recommended that men should be counseled on the potential risk
of HIV and HSV2 transmission given their serostatus and programs that conduct male
circumcision procedures should promote sexual abstinence during wound healing and condom
use thereafter.23
A population that has growing risk for HIV infection in Uganda is the population
involved in sex work. A segment of this population in Uganda is composed of female sex
workers (FSWs) who in Uganda account for 35 percent of the nation's HIV1 prevalence.70
Another segment of this population is composed of the male partners and clients of these female
sex workers (MPCSWs). Although, scarce literature exists demonstrating the risk factors of
FSWs for HIV1, there exists even less literature of MPCSWs. Through available studies,
including Uganda, researchers have found that specifically male clients of sex workers contribute
disproportionally to HIV prevalence.4,21,35,40,49,57 For Uganda, in particular, 80% of new
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infections are accounted for by heterosexual transmission.70 Because the increasing incidence of
Uganda is largely accounted for by heterosexual transmission HIV1, exploring the attitudes and
behaviors of both partners and clients of female sex workers may provide insight into potential
risk factors that can lead to both HSV2 and HIV1 infection in the population involved in sex
work.
1. 2 General Objective
The following study will explore a group of MPCSWs and the potential risk factors that this
segment of the sex work population may contribute to HIV1 and HSV2 prevalence in the sex
work population in Kampala, Uganda. MPCSW data for this study were obtained from data
collected by the Crane Survey which was conducted in 2008-2009 with the collaboration of the
Uganda Ministry of Health, STD/AIDS Control Programme, Makarere University School of
Public Health, and the Centers for Disease Control and Prevention.
SPECIFIC OBJECTIVES
1. Identify risk factors for both HSV2 and HIV1 outcomes in the Crane survey sample of male
partners of sex workers and to then study the factors associated with the four groups of persons
cross-classified by HSV2 and HIV1 serostatus, as follows.


(HIV1+, HSV2+)



(HIV1+, HSV2-)



(HIV1-, HSV2+)



(HIV1-, HSV2-)
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CHAPTER II
Review of the Literature
2.1 Overview of HIV1 (Human Immunodeficiency Virus Type 1) and HSV2 (Herpes
Simplex Virus Type 2)
The first case of HIV was identified in early 1959 from an adult Bantu male who lived in
Kinshasa, Democratic Republic of Congo.52,54 At the time he did not know how he was infected
and research could not identify how neither.52,54 Through many following studies since then, it
has become evident that HIV was the result of virus infected primates in Africa transferring this
virus to humans, zoonotic transfers.27 The origins of HIV still remain a mystery and many
theories have been argued countless times of the virus's origin. Its first discovery was made in
1984 by Luc Montagnier and colleagues at the Pasteur Institute in Paris.75
Today, the generally accepted theory of HIV's origin stems from the virus being a
descendent of a Simian Immunodeficiency virus. HIV1 is the more virulent and the pandemic
strain. HIV1's origin was determined only recently in 1999 in a subgroup of Chimpanzees (Pan
troglodytes trolodyte)that were once native to west-Central Africa. This discovery was led by
Paul Sharp of Nottingham University and Beatrice Hahn of the University of Alabama where
after a 10- year long study they concluded that wild chimps were infected simultaneously with
two different simian immunodeficiency viruses and gave rise to a third virus that could be passed
on to other chimps and could have crossed species into humans and causing AIDS.3,20
HIV is a lentivirus meaning 'slow virus' and like all viruses of its type attacks the
immune system and takes a long time to produce adverse effects.86 HIV only affects humans and
causes the weakening of the immune system by killing its important cells, namely CD4 cells.2 By
5

weakening the "defense system" of the human body, the immune system, the infected body is left
vulnerable to other agents of infection.2 HIV currently has no cure, and if the infected body
reaches a certain low number of viable CD4 cells there remain no way for the body to fight off
infections and diseases.2 If this occurs, a person will have progressed to the condition, AIDS.1
AIDS is the acronym that stands for "Acquired Immunodeficiency Syndrome" and is
known as the last stage of HIV infection before death. Death usually occurs from opportunistic
infections acquired during the AIDS condition. However, it is important to note that not all HIV
infected individuals reach the progression of AIDS due to the help of available anti-retroviral
medications.2
HSV (Herpes Simplex Virus) was known to be prevalent as early as in ancient Greek
times.83 Greek scholars, notably Hippocrates, defined the Greek word "herpes" to mean "to creep
or crawl" in reference to the spread of the virus lesions.83 In 1886, two French doctors, CharlesPaul Diday and Adrien Doyon published a text about herpes called "The Genital Herpes".31 In
1893, the Herpes Simplex viruses were established by Dmitri Ivanoski in Russia and French
scientist Emile Vidal proved that herpes was transmitted from person to person.31 In 1925, an
American virologist Ernest Goodpasture proves that the herpes virus travels through the nerves.31
In 1939 Frank LacFarlane Burnet, an Australian microbiologist, developed the theory of latency
where the herpes virus resides when the person affected is asymptomatic.31 Lastly, Gertrude
Elion developed in 1978 the first safe and non-toxic anti-viral drug, Acyclovir. To date there is
still no cure for HSV viruses.31
There are two types of Herpes Simplex viruses, type 1 and type 2. Both virus types share
many biological similarities based on a similar genome structure where 40% of sequence
homologies reach 83% homology of their protein-coding regions.47 Infecting the body's mucosal
6

surfaces/abraded skin and establishing latency in the nervous system are characteristic of both
types, however, sites of infection and latency differ between the two types.82 Herpes Simplex
Type 2 ( HSV2) is more associated with herpes that is sexually transmitted, where the virus
infects the genital, perigenital, or anal mucosa/abraded skin and latency reside in the sacral
ganglia.82
Certain triggers are noted to cause the virus to come out of latency or from the nerve cells
and reactivate to form lesions and blisters. These reactivation triggers are commonly found to be
the following: stress, fever, exposure to ultraviolet light, tissue damage, and
immunosuppresion.82 Currently, there is no cure for HSV. Medications such as Famvir, Zovirax,
and Valtrex can decrease pain from blisters and decrease total number of outbreaks.32 Warm
baths are known to decrease the pain with genital sores.14
2.2 Burden of HIV1 and HSV2
About 34 million individuals worldwide were living with HIV/AIDS at the end of 2011.72
Of these 34 million, only 50% know their HIV status.74 The major risk factors of HIV infection
include: unprotected sex (especially with multiple partners), having another sexual transmitted
disease, use of intravenous drugs and lack of male circumcision.34 Major groups that are termed
“vulnerable” to the HIV epidemic are the following: MSM (men that have sex with men), people
who inject drugs, sex workers, young women and transgender people.28 MSM is the group that is
most affected by the HIV epidemic. MSM has a high burden of HIV due to the high per-act and
per-partner transmission probabilities during anal sex.5 MSM also have higher rates of dualvariant and multiple-variant HIV infection than heterosexual people in the same setting.5 In
many parts of Africa, Asia, and Latin America, the highest rates of HIV infection in any risk
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group are in these men.6 Although data on MSM are limited and not readily comparable, global
prevalence of HIV in this group appears to have increased from 2010 to 2012.72
It is estimated that 0.8% of adults aged 15 to 49 years old are living currently with HIV.8 The
burden of the epidemic varies greatly between countries and regions, where sub-Saharan Africa
(SSA) continues to be the most affected region, where 1 in 20 adults are living with HIV and
accounts for 69% of the people living with HIV globally.12 Despite this, a decrease has been
observed in HIV deaths globally since 2001. It is reported that HIV deaths decreased slightly
from 1.7 million deaths in 2000 to 1.5 million deaths in 2012.43 From the mid-2000s the number
of deaths from AIDS-related causes has fallen constantly due to increasing access to
antiretroviral therapy (ART) and this access is estimated to have added 14 million life-years in
low-and middle-income countries since 1995.37,43 At the end of 2011, the 8 million people who
utilized ART were a 20-fold increase since 2003.72
Although a decline in HIV deaths is observed, when observing age-standardized death
rates between 1990 and 2010 for AIDS, there was a decline of 21.5% in all cause death rates
compared to a 258% increase in the age-standardized death rates for AIDS.48 Also, years lived
with disability per 100,000 increased 2.5% for all cause death rates in comparison to 109.4% for
HIV during the same years.76 HIV and AIDS are still the fifth leading cause of global disabilityadjusted life years (DALYs). HIV/AIDS was ranked as the leading DALY cause for ages 30-44
years in both sexes and for 21 countries that fall in the following four regions: Eastern and
Southern Africa, Central Africa, the Caribbean and Thailand. Also, 20% of the global HIV/AIDS
burden was accounted in countries where HIV/AIDS was not one of the ten leading causes of
burden.56 Worldwide, the rate of HSV infection, including both HSV-1 and HSV2 is about
90%.78 HSV2 is more common in Sub-Saharan Africa than in Europe or North America.81 This
8

region is home to highest levels of HSV2 infection where up to 82% of women and 53% of men
are seropositive.45 In most African countries, HSV2 prevalence increases with age.36 However,
age-associated decreases in HSV2 have been reported in Uganda, Zambia, and Benin.65
Those that pose of highest risk are "asymptomatic" individuals which causes for
individuals infected to not be detected and pose a risk to those who are vulnerable.9 Vulnerable
populations of HSV2 are cancer chemotherapy patients and children being born to mother who
have HSV2 who aren't treated.11 HSV2 can be passed vertically from mother to child during
birth. Most children being born to a mother with HSV2 die 80% of the time if they do not receive
treatment.8 Those that do survive often acquire brain damage.8 HSV2 can also be passed
horizontally and infect sexual partners. HSV2 is found to be associated with an increased risk of
two-to threefold for HIV acquisition.80
2. 3 Prevention and Control of HIV1 and HSV2
By the mid-2000's the main form of prevention and control of HIV started as a
combination of interventions. These interventions' purpose are to be effective in controlling and
preventing the spread of HIV. These combination interventions take into account underlying
socio-cultural, economic, political, legal and many other factors in people's lives. This strategy is
more of a holistic approach where behavioral, biomedical and structural prevention strategies to
the spread on HIV are implemented. These interventions consider factors such as levels of
infrastructure, local culture and traditions as well as populations most affected by HIV. These
programs can be implemented at all population levels. UNAIDS has called for these approaches
to HIV prevention to be scaled up and to reinvigorate the global response in order to create an
impact on global HIV incidence rates.73
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Another plan, held in the United States, is called Division of HIV/AIDS Prevention's
Strategic Plan 2011-2015. The purpose of the plan is to lessen the burden of HIV as much as
possible from the years 2011 through 2015. The plan allows for new opportunities and
imperatives for HIV prevention created by large changes in the national, state, and local
economic and policy environments, including the July 2010 release of the National HIV/AIDS
Strategy for the United States (NHAS). DHAP strives for high-impact prevention using scalable,
cost-effective interventions with the benefit of reducing the HIV epidemic impact.85
HSV2 does not have a plan of its own globally, but can be controlled and prevented like
many other sexually transmitted diseases. Knowing the numerous and apparent problems
concerning the spread of HSV2 makes knowing the correct steps and history in regards to
preventing and controlling it of principal importance. According to the CDC, the correct and
consistent use of latex condoms can reduce the risk of genital herpes however; outbreaks can
occur in areas that are not covered by a condom which makes it prevention extremely
problematic as stated in the former section. Furthermore; the best course of action to take in its
prevention is to abstain from sexual contact or to be in a long-term mutually monogamous
relationship with a partner who has been tested and is known to be uninfected . Knowing when to
refrain from sexual acts with individuals who have the classic ulcerations around their genitalia
goes a long way in the first steps of its prevention. Next, it’s important to know that even if a
person does not have any symptoms that he or she can still infect sex partners. Sex partners of
infected persons should be advised that they may become infected and they should use condoms
to reduce the risk. Sex partners can seek testing to determine if they are infected with HSV2.67
Screening and testing for the existence of HSV2 antibodies in one’s bloodstream remains
the best way to prevent giving the disease to another person.38 Prevention starts with knowledge
10

because everything one does in prevention, management and control depends upon it. Knowing
what not to do is just as important as knowing what do to in this aspect. One facet to the
decreased spreading of HSV2 is using suppressive antiviral therapy because these types of drugs
can diminish risks of transmission by up to 50%.44 Antivirals also help thwart the development
of symptomatic HSV2 infections. Condom are of course another form of prevention like we
mentioned above; but it is much more effective at foiling male-to-female transmission than the
other way around.79 Consequentially; the use of the condoms combined with antiviral drugs
increases the chances of not acquiring HSV2 by more than 75%. Individuals with an already
existing HSV-1 infection diminish the risk of obtaining HSV2 infection among women by a
factor of three.85 In addition; each time the anti-HIV drug tenoforvir was used within a topically
microbicide vaginal gel it was described to lessen HSV2 sexual transmission by more than 50
percent.2
2.4 HIV1 and HSV2 in Uganda
Uganda is located in East-Central Africa, west of Kenya, and has a population of about
36 million.43 Currently, about 7.2 percent of Uganda's population is living with HIV, which
encompasses about 1.4 million people including 190,000 children.45,47 Recent estimates
demonstrate that 62,000 people died from AIDS in 2011 and 1.1 million children have been
orphaned by Uganda's epidemic.72 The first Ugandan case of AIDS was diagnosed in 1982.62 In
the mid 1980’s, AIDS became a visible issue in Uganda and efforts to combat this problem
began shortly after its discovery.14 In Uganda, AIDS originated in rural Uganda in the area of
Lake Victoria and was termed “Slim Disease”.62 AIDS during this time spread along urban
sexual network and major highways.62
By the implementation of the A B C prevention strategy in 1992, there was strong
11

leadership, open communication and involvement of numerous grassroots organizations like
TASO (The Aids Support Organization), expanded condom distribution, HIV testing and
treatment of sexually transmitted infections.16,42,44 The message that was disseminated through
these efforts started with President Musevini starting in 1986 with his message to maintain
fidelity in relationships in Uganda.33 Filipino Secretary of Health, Dr. Juan Flavier, is credited
with being the first to articulate the " A B C" approach. The early history of the " A B C"
approach started when the United States Agency for International Development (USAID) during
the high onset of HIV/AIDS in the mid 1980's undertook two large scale projects called the
AIDS Public Health Communication Project (AIDSCOM) and the AIDS Technical Support
(AIDSTECH) Project in response to the increase of HIV/AIDS.29 Of these two programs,
AIDSCOM was directly involved in strategically targeting campaigns for behavior change
involved in HIV/AIDS.16 AIDSCOM ran from 1982 to 1992.16 AIDSCOM is recognized as the
program that gave way to the first ideas to the " A B C" approach by using an applied behavior
change (ABC) framework, which integrated behavioral and social psychology, social marketing
and communication.15 AIDSCOM's early work was conducted in the following countries: the
Philippines, the Eastern Caribbean, Jamaica, the Dominican Republic, and Ghana.21 The major
focus in these nations via AIDSCOM's behavior change communication campaigns were either
abstinence, fidelity or condom use.29 These campaigns advocated for one or two of these
behavior changes, but never all three behavior changes together comprehensively.29
The Philippines experienced their first case of HIV in 1984. During the early 1990's,
Philippines had increasing numbers of HIV and at this time started to face tension about issues of
sexuality between the Philippine Department of Health (DOH) and the Catholic church. During
the same time, Secretary of Health, Dr. Juan Flavier, a Catholic physician who dealt with both
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DOH and the Catholic church with a family planning program, undertook a nation-wide,
important campaign.18 The goals of this campaign were to increase awareness of HIV/AIDS and
promote HIV prevention behaviors through public discussion of condom use.18 Dr. Juan Flavier
during this time continued to pursue the goals of the campaign by doing activities such as giving
members of the media condoms during the preparation for a presidential trip to Thailand in 1992
where the DOH proclaimed that December to be "National AIDS awareness month" and
implemented a range of AIDS education and activities due to increasing HIV prevalence in
Thailand.46 Through this act , Dr, Juan Flavier, won the allocation of money for HIV prevention
programs by the Philippines Congress.29
Through this achievement, Dr. Juan Flavier, continued his close work with HIV
prevention programs with the church where he was always careful to use scientific evidence as
the basis for future programs to avoid debates of morality. Dr. Juan Flavier always believed that
AIDS was avoidable, however, crucial steps had to take place to do so. Dr. Juan Flavier then was
the first to articulate the " A B C" approach, where denoted it to be the following: A represented
abstain from sex, B represented be faithful if you cannot abstain, keep one partner and C
represented be careful and use a condom if you cannot be faithful.29
Dr. Juan Flavier's "A B C" constructed approach at this time gained popularity
worldwide. Dr. Juan Flavier took advantage of media and public speaking opportunities to
spread messages about HIV prevention. Examples of these opportunities included: international
presentations, International AIDS conferences, meeting of health ministers, and at the 1994
International conference on Population and Development.65
The A B C strategy to combat HIV/AIDS in Uganda is the main intervention that is
thought to be responsible for the decrease in HIV prevalence in Uganda from 1991 at about 15%
13

to about 5% in 2001 from analysis of surveys conducted in both 1988 (women only), 1995
(women and men) and 2000 (women and men) from Uganda’s Demographic and Health Survey
(DHS) and Global Programme for AIDS (GPA) surveys conducted in 1989 (women and men)
and 1995 (women and men).64 It is still unclear as to what segment of the A B C intervention
sexual behavior changes that led to the decline in HIV prevalence during these times.25 Key roles
that have led to the decline include: changes in sexual debut, casual and commercial sex trends,
partner reduction and condom use.25
The President’s Emergency Plan for AIDS relief (PEPFAR) and Prevention of Mother to
Child Transmission (PMTCT) are two prevention interventions that followed in 2004 and 2002,
respectively, and that also provided assistance with antiviral medication access to those infected
by HIV/AIDS globally. Despite the onset of these new interventions, HIV prevalence has failed
to decline much further and has been pretty stable between 6 and 7 percent.84 Additionally, there
has been an observed increase in prevalence rates in Uganda since 2006.50
Critics argue that the reason for the incline may be due to the strict abstinence approach
PEPFAR has taken in their efforts in 2003.19 Critics have also argued that the A B C
intervention, has had efforts concentrated around A and B. The intervention has focused on
individual behaviors.53 The A B C approach fails to acknowledge factors that make people
vulnerable to HIV/AIDS. The intervention dismisses the real social, political and economic
causes of the epidemic.53 Infected people are then blamed because they didn’t adopt the A B C
intervention. Further, the ABC intervention ignores vulnerable populations such as sex workers
and those who lack the ability to negotiate safe sex.53 Presently, in Uganda this abstinence
program is still in effect today.
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Little is known about HSV2 in Uganda, and even less so of programs implemented for
HSV2 control and prevention despite studies that demonstrate high prevalence of HSV2 in the
population, among them women.7
2.5 HIV1 Risk Factors Involved amongst Female Sex Workers (FSWs) and their Male
Partners and Clients of Female Sex Workers (MPCSWs)
The relationships between FSWs and their MPCSWs is a notable one since factors that
pose FSWs at higher risk for HIV are interrelated with the behavior and attitudes of their
MPCSWs. These behaviors include: homosexual behaviors of MPCSWs, gender-based
expectations, violence, drugs for pleasure and condom use with multiple partners. Gay and
bisexual men of all ages and races are disproportionally the more severe affected group by HIV.2
These men, including those men that are transgender are termed MSM (men that have sex with
men). Statistics demonstrate that MSM are 19 times more likely to be living to be living with
HIV than the general population in low-and middle-income countries. Also, it has been found
that in MSM populations that proportions of these men display bisexual behaviors. These
bisexual behaviors have been extensively documented in Kenya. A study conducted in Nairobi
found that 23% of MSM reported being bisexual although 69% reported ever having sex with a
woman. It was also found that 14% of these MSM were currently married or had ever been
married to a woman.6 In another study from Kenya it was found that 60% of 285 MSM reported
having female sexual partners.60 These studies demonstrate that MSM may be a bridge
population for HIV infection between MPCSWs and FSWs.
Gender-based expectations can also pose as a risk factor for HIV infection. In many
countries women are expected to display more submissive behavior when it comes to sexual acts.
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This may deter women from feeling empowered to access sexual health information and
services.33 Men, on the other hand, may link masculinity with taking risks and demonstrating
toughness. This behavior could also deter men from seeking HIV testing and treatment.4
MPCSWs can also play a part in perpetuating violence when coming into contact with an
FSW. FSWs are usually stigmatized and criminalized in many societies and worldwide there is
scarce legislation and policies implemented to protecting sex workers.60 The lack of protective
infrastructure for sex workers can make FSWs be more susceptible to being vulnerable to
acquiring HIV infection.63 A recent systematic review determined that lifetime prevalence of any
or combined workplace violence that sex workers encountered ranged from 45% to 75%.17
Particularly in Uganda, a study found that FSWs were aware of HIV knowledge and risk,
however, due to the fear of violence and the financial need to survive these women viewed HIV
as being less of a risk than the violence they faced for them to survive.61
It is known that proper condom use is effective at preventing STIs, including HIV.1,37
Sex workers have more sex partners when compared to the general population. Although,
increasing the number of sex partners poses a risk to HIV acquisition, it has been found that if
condoms are used properly and consistently the number of partners does not increase the
likelihood of HIV acquisition.67 There are few studies that have surveyed PSWs and their
condom use with female sex workers. One study, conducted in Kenya with a population of truck
drivers as MPCSWs determined that MPCSWs had a high HIV1 seroprevalence rate upon entry
and release from the study and risk factors determined from this group included low condom use
and uncircumcised status to contribute to HIV infection.53
Lastly, drugs for pleasure such as alcohol is well documented to be associated with HIV
prevalence.13 Alcohol consumption has been long recognized as an important aspect of
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commercial sex.58 Studies have found that alcohol use in commercial sex has led to FSWs being
victimized during violent acts by their partners and have also led to higher number of
unprotected sex.11,22,41
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CHAPTER III
METHODS AND PROCEDURES
3.1 Data Source
Data obtained for this thesis analysis was provided by The Centers for Disease Control
and Prevention in Atlanta, Georgia. Specifically, the data provided is a subset of the data
collected that originated from The Crane Survey 2008/2009 and clinical data that were obtained
for this survey. This survey and obtained clinical data was used as a tool to monitor HIV
occurrence and prevention with its concerns and parameters being focused to most at risk
populations from May 2008 until April 2009 in Kampala, Uganda. The Crane Survey and
collection of clinical data was completed with the collaboration of Uganda Ministry of Health
STD/AIDS Control Programme, Makerere University School of Public Health, and the Centers
for Disease Control and Prevention. In this study, I have limited analysis to the most-at-risk
population from the original collected data:male partners and clients of female sex workers
(MPCSWs).
3.2 Study Sample in Analysis
The analysis conducted for this thesis was a secondary analysis of survey responses and
clinical data obtained, as previously described, from a sample of 520 men who were male
partners and clients of female sex workers in Kampala, Uganda.
3.3 Independent and Dependent Variables
Scientifically relevant independent variables that had 10% missing or less that were used
for this analysis are displayed in Table 1 in the Results section of this thesis. Ten independent
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variables were chosen for this study to compare their influences in the population cross-classified
by serostatus of HIV1 and HSV2. Eight of these ten predictors were dichotomous categorical
variables and two of these categorical variables were modified. The six unmodified variables
were: circumcision status, ever had anal intercourse with a man, ever used a male condom, had
casual intercourse in the last 6 months, presence of genital ulcer/sore in the past 12 months and
ever married status. The two categorical predictors that were modified due to low counts in cells
were "drank alcohol in the last 30 days" and "sexual orientation." "Drank alcohol in the past 30
days" had original levels: about every day, at least once a week, less than a week, none. These
levels were modified by collapsing original levels dichotomously to None and At least Once a
week for analysis. "Sexual Orientation" had original levels: Homosexual, Bi-sexual, and
Heterosexual. These levels were modified by collapsing them dichotomously to Hetero and
Homo/Bi. The remaining two predictors used in analysis were continuous variables that were not
modified. These were "age" and "# lifetime female sexual partners".
The four dependent variables used for this analysis were created from the clinical data
that provided serostatus of HSV2 and HIV1 for male partners and clients of female sex workers.
Using these data four dependent dichotomous variables were constructed to represent the crossclassification of serostatus for the population understudy.

3.4 Statistical Analysis
All analyses were conducted using SAS 9.4. Descriptive statistics for the study were
conducted by identifying frequency distributions of categorical variables (including modified
variables) and distributions of continuous variables. Missing data were discovered during the
development of frequencies and distributions of study variables. This information is reported in
Table 2 of the results section.
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Multiple logistic regression models were used to determine associations between each
independent variable and each cross-classified serostatus outcome. The level of significance of
all analyses was α=.05. With logistic regression, the dependent variable is dichotomous. The log
odds of the outcome of interest is a linear function of the independent variables. The regression
coefficients measure change in log odds associated with a one unit change in the independent
variable. In SAS, logistic regression is conducted using the PROC LOGISTIC procedure.

Four logistic regression models were constructed in this study where each model
consisted of the same 10 independent variables chosen for analysis and a cross-classified
serostatus of the population represented the dependent variable. Once significant associations of
independent variables with their respective cross-classified serostatus outcomes were obtained,
these findings were then compared among the four cross-classified outcomes for this population.
Statistics of associations found can be observed in Tables 3-6 and Table 7 in the Results section.
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CHAPTER IV
RESULTS
4.1 Descriptive Statistics of HSV2, HIV1 Serostatus within Chosen Study Variables
Table 1 lists the independent variables of interest that will be used for multiple logistic
regression analysis and their respective values. Table 2 depicts descriptive statistics of each
independent variable for each of the four cross-classified HSV/HIV serostatus outcome groups.
As mentioned previously the four cross-classified serostatus outcome groups are the following:
(HIV1+, HSV2+), (HIV1+, HSV2-), (HIV1-, HSV2+), (HIV1-, HSV2-). As Table 2 displays,
there were a total of 520 male partners and clients of sex workers (MPCSWs) that were included
in analysis. While obtaining descriptive statistics of independent variables it was discovered that
some of these variables contained missing observations. Missingness is reported in the footnote
to Table 2. The two continuous independent variables used in analysis were found to have
skewed distributions when observing their histograms, therefore, median and interquartile range
(IQR) were reported as the descriptive statistics for each of the four serostatus outcome groups in
Table 2.
The following frequencies were observed in each of the cross-classified serostatus
groups: (HIV1+, HSV2+) n=74, (HIV1+, HSV2-) n=24, (HIV1-, HSV2+) n=113, (HIV1-,
HSV2-) n=309. About double the amount of men were found to have cross-classified serostatus
(HIV1-, HSV2-), (42.1%) when compared to those men that had cross-classified serostatus
(HIV1+, HSV2-), (20.8%) and (HIV1+, HSV2+), (20.3%) for those men that reported having
been circumcised. Also, about double the amount of men were found to have cross-classified
serostatus (HIV1+, HSV2-), (70.8%) and (HIV1+, HSV2+), (78.2%) when compared to those
men that had cross-classified serostatus (HIV1-, HSV2-), (35.8%) for those men reporting ever
21

been married. Lastly, a difference was observed in frequencies of cross-classified serostatus in
the population understudy was observed in those men that reported having a genital ulcer/sore.
Almost double the amount of men were found to have cross-classified serostatus (HIV1+, HSV2), (58.3%) and (HIV1+, HSV2+), (61.1%) when compared to those men that had cross-classified
serostatus (HIV1-, HSV2-), (32.3%).
4.2 Multiple Logistic Regression Analysis
Multiple logistic regression analysis was implemented to build models using the ten
independent variables with each of the four cross-classified serostatus outcomes in order to
discover associations between the study variables and the serostatus outcomes in each model.
Tables 3 through 6 display the findings of significant associations for each of the four models.
Table 7 provides a comparison of odds ratios of cross-classified serostatus for each of the ten
study variables from collected data from Tables 3 through 6. Below is reported significant
findings of all cross-classified serostatus outcomes.
Table 3 presents the statistics for the model that contains (HIV1-, HSV2-) cross-classified
serostatus outcome. In this model 3 of the 10 study variables were found to be significant. These
significant predictors were: "presence of a genital ulcer/sore in the last 12 months", "ever been
married", and "age". For those men that reported having had a presence of a genital ulcer/sore in
the last 12 months, holding all other independent variables constant, were found to have an odds
ratio of 0.52 compared to those men that reported having not had a genital ulcer/ sore in the last
12 months for those men who were cross-classified serostatus (HIV1-, HSV2-). This odds ratio
demonstrates a protective effect where men that reported having had a genital ulcer/sore in the
past 12 months are 48% less likely to have this cross classified serostatus. For those that have
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ever been married, holding all other independent variables constant, men who reported ever been
married were found to have an odds ratio of 0.52 compared to those men that reported having not
ever been married for those men who were cross-classified serostatus (HIV1-, HSV2-). This
odds ratio also demonstrates a protective effect where men that reported having ever been
married are 48% less likely to have this cross classified serostatus. For the independent variable
"age", holding all other independent variables constant, the odds of men obtaining a (HIV1,HSV2-) cross-classified serostatus decreases by 10% for every one unit (year) increase in age.
This independent variable was found to have an odds ratio of 0.90 and also reflects a protective
effect against (HIV1-, HSV2-) whereas age increases this serostatus is less likely.
Table 4 presents the statistics for the model that contains (HIV1-, HSV2+) crossclassified serostatus outcome. In this model 1 of the 10 study variables was found to be
significant. For the independent variable "age", holding all other independent variables constant,
the odds of men obtaining a (HIV1-,HSV2+) cross-classified serostatus outcome increases by
6% for every one unit (year) increase in age. This independent variable was found to have an
odds ratio of 1.06 and reflects a risk effect for (HIV1-, HSV2+) whereas age increases this
serostatus is more likely.
Table 5 presents the statistics for the model that contains (HIV1+, HSV2-) crossclassified serostatus outcome. In this model 2 of the 10 study variables were found to be
significant. These significant predictors were "ever been married status" and "circumcision
status". For those that have ever been married, holding all other independent variables constant,
men who reported ever been married were found to have an odds ratio of 2.90 compared to
those men that reported having not ever been married for those men who were cross-classified
serostatus (HIV1+, HSV2-). This odds ratio also demonstrates a risk effect where men that
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reported having ever been married are 190% more likely to have (HIV1+, HSV2-). For those
men that reported having been circumcised, holding all other independent variables constant,
were found to have an odds ratio of 0.26 compared to those men that reported having not been
circumcised who were cross-classified serostatus (HIV1+, HSV2-). This odds ratio demonstrates
a protective effect where men that reported having been circumcised are 74% less likely to have
this cross classified serostatus.
Table 6 presents the statistics for the model that contains the (HIV1+, HSV2+) crossclassified serostatus outcome. In this model 3 of the 10 study variables were found to be
significant. These significant predictors were: "presence of genital ulcer/sore in the last 12
months", "circumcision status", and "age". For those men that reported having had a presence of
a genital ulcer/sore in the last 12 months, holding all other independent variables constant, were
found to have an odds ratio of 2.29 compared to those men that reported having not had a genital
ulcer/ sore in the last 12 months for those men who were cross-classified serostatus (HIV1+,
HSV2+). This odds ratio demonstrates a risk effect where men that reported having had a genital
ulcer/sore in the past 12 months are 129% more likely to have this cross classified serostatus. For
those men that reported having been circumcised, holding all other independent variables
constant, were found to have an odds ratio of 0.48 compared to those men that reported having
not been circumcised who were cross-classified serostatus (HIV1+, HSV2+). This odds ratio
demonstrates a protective effect where men that reported having been circumcised are 52% less
likely to have (HIV1+, HSV2+). For the independent variable "age", holding all other
independent variables constant, the odds of men obtaining a (HIV1+,HSV2+) cross-classified
serostatus outcome increases by 8% for every one unit (year) increase in age. This independent
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variable was found to have an odds ratio of 1.08 and reflects a risk effect for (HIV1+, HSV2+)
whereas age increases this serostatus is more likely.
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CHAPTER V
DISCUSSION AND CONCLUSION
Discussion
Findings from this study discovered significant associations between certain independent
variables studied and one or more cross-classified serostatus of HIV1 and HSV2 as stated
previously. As noted before, these independent variables included: "presence of genital
ulcer/sore," "ever married status," "age" and "circumcision status". Although these variables
were found to have a significant association with at least one of the cross-classified serostatus
groups, significant associations were not detected across all cross-classified serostatus groups for
any of these given variables. A possible explanation for this discovery is found in a study where
researchers reviewed the available literature involving male circumcision and sexually
transmitted effects, including HIV1 and HSV2, in adulthood. 69 The researchers found that many
of the studies they reviewed were observational studies that contained limited statistical power,
were vulnerable to confounding, and contained limitations of self-reporting. 69
The nature of this study involves sexually transmitted effects, is also observational,
specifically cross-sectional, and responses for independent variables studied were limited to selfreporting. Since the nature of this study is closely related to what the researchers in the study
discovered of other related observational studies, it is possible that this study may also contain
limited statistical power and can possibly explain and provide insight into why all the crossclassified serostatus groups were not found to be significant given that an independent variable
was found to have a significant association with at least one of these cross-classified serostatus
groups. The following discussion will take into consideration a possible statistical power issue
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and will describe observed differences in obtained odds ratios across cross-classified serostatus
groups for independent variables that were found to have at least one significant association with
a cross-classified serostatus group and based on these differences describe possible implications.
Table 7 displays the odds ratio results of each cross-classified serostatus for each study variable
used in analysis. Significant results are depicted in bold.
For the independent variable, "presence of genital ulcer/sore in the last 12 months", an
important comparison exists between (HIV1-, HSV2+) and (HIV+, HSV2+). As depicted in
Table 7, the odds ratios for these cross-classification serostatus are 1.08 and 2.29 respectively.
These two odds ratios demonstrate a large difference and this difference indicates that the
presence of HIV1 may be important in acquiring HSV2 when a genital ulcer is present within the
last 12 months. Another odds ratio comparison between (HIV1-, HSV2+) and (HIV1+, HSV2-)
has odds ratios 1.08 and 2.50 respectively. These odds ratios demonstrate a large difference as
well and further support the presence of HIV1 being an important factor when a genital ulcer is
present in the last 12 months. Specifically, the presence of HIV1 in the absence of HSV2 is more
likely when a genital ulcer is present in the last 6 months than in the absence of HIV1 and the
presence of HSV2. Lastly, when comparing these odds ratios to the odds ratio of (HIV1-,
HSV2-), 0.52, a large difference is also observed and as stated before the presence of a genital
ulcer in the last 12 months is protective against (HIV1-, HSV2-). These odds ratios collectively
reflect that presence of HIV1 has influence in the presence and absence of HSV2 when a genital
ulcer is present in the last 12 months.
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Evidence from the literature has found that genital ulcerative disease usually caused by HSV2,
allows for HIV1 susceptibility to increase through the disruption of the mucosal barrier
associated with ulceration, and genital shedding which causes increases in HIV1
infectivity.13,26,36,39,43,51,66
For the independent variable ,"ever been married", the comparison between (HIV1-,
HSV2+) and (HIV+, HSV2+) is similar, 1.38 and 1.74 respectively. However, this difference
indicates that the presence of HIV1 may be an influence in acquiring HSV2 when the person has
ever been married. The comparison between (HIV1-, HSV2+) and (HIV1+, HSV-) which has
odds ratio 2.90 reflects a large difference and demonstrates that a person who has ever been
married is more likely to have a presence of HIV1 in the absence of HSV2 than is to have a
presence of HSV2 and an absence of HIV1. This comparison reflects the influence of the
presence of HIV1 when a person has ever been married. Lastly, the comparison of these odds
ratios compared to the odds ratio of (HIV1-, HSV2-), 0.52, once more shows a protective effect
against this cross-classified serostatus when a person has ever been married. Evidence from the
literature provide evidence for the influence of the presence of HIV1 when a person has ever
been married. The 2004 Behavioral Surveillance survey indicated that the highest rates of HIV1
infection occur among married men and unmarried women.30 Researchers believe these high
rates are due to cultural and societal expectations of gender roles in Uganda.49 Researchers have
found that in Uganda, "men generally have more power in sexual relationships, and not expected
to be faithful, often use violence as a way to resolve conflicts, and are not involved in
reproductive health matters, including HIV testing and disclosure." 49 In addition, a 2006 study
conducted by the Uganda AIDS commission determined that controlling for these gender role
imbalances would play a large role in HIV prevention.10
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For the independent variable,"age", the odds ratio comparison between (HIV1-, HSV2+)
and (HIV+, HSV2+) is also similar, 1.06 and 1.08 respectively. However, this slight difference
indicates that the presence of HIV1 may be a slight influence in acquiring HSV2 with increasing
age. When comparing these odds ratios to the odds ratio of (HIV1-, HSV2-), a protective effect
against this cross-classified serostatus is observed with odds ratio 0.90 is observed. Evidence
from the literature reflects both presence of HIV1 and presence of HSV2 as an implication as age
increases. A study from Rakai, Uganda determined that HSV2 prevalence in men increased with
older age.68 Another study conducted in rural Rakai, Uganda where among girls aged 15-19, the
adjusted relative risk of HIV1 infection doubled among those reporting a most recent sexual
male partner that was 10 or more years older.44

Lastly, for the independent variable "circumcision status", the odds ratio comparison
between (HIV1-, HSV2+) and (HIV1+, HSV2+) is very large, 1.35 and 0.48 respectively. These
findings indicate that the presence of HIV1 may be important in acquiring HSV2 when a person
is not circumcised and the presence of HIV1 when HSV2 is also present allows for a protective
effect for those that are circumcised. The influence of HIV1 is also reflected when these odd
ratio findings are compared to the odds ratio of (HIV1+, HSV2-), 0.26. The presence of HIV1
still demonstrates a protective effect in the absence of HSV2 for those that reported being
circumcised. Lastly, comparing the odds ratio of (HIV1-, HSV2-), 1.53, to the odds ratios of
(HIV1+, HSV2+) and (HIV1+, HSV2-) the absence of HIV1 and HSV2 is more likely when
circumcision has taken place. Evidence from the literature provide evidence for the absence of
HIV1 when a person is circumcised. Findings were supported by a study that reviewed the
available literature regarding male circumcision and sexually transmitted infection effects in
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adulthood and reported significant effects based on randomized controlled trials. The study
found from 3 randomized controlled trials conducted in South Africa, Kenya and Uganda that
discovered that circumcision decreases the acquisition of HIV1 by 53% to 60% among
heterosexual men.69 The study also discovered two randomized controlled trials conducted in
Uganda and South Africa whose findings indicated that circumcision decreases the acquisition of
HSV2 by 28% to 34%.69

Limitations
Despite the statistical results agreeing with literature findings, limitations were faced
through this analysis. The quality of survey questions constructed from the primary investigators
were poor and could have been constructed in a more tailored method for the population studied.
Another limitation to this study is missing data. The data that was missing if was made available
could have allowed for a more accurate characterization of these men in the study. Lastly,
another limitation is that, with the exception of HIV1 and HSV2 serostatus data, the data was
self-reported.
Conclusion
Findings from this study discovered that reporting the presence of a genital ulcer/sore in
the past 6 months, reporting ever been married, and increased age give higher odds for HSV2+,
HIV+ and HIV+ and HSV2+ respectively. Similar findings have also been discovered previously
in the literature. Given the evidence presented in this study and findings from previous studies of
these identified risk factors, more tailored surveys and studies must be implemented to precisely
understand the sexual risk behaviors of MPCSWs and other marginalized populations. With a
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more favorable method of survey methodology tailored to MPCSWs and that account for
documented risk factors, a clearer picture can be achieved to understand the prevention methods
needed in the MPCSWs.
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Table 1. All study variables.
Variable
Ever used a male condom
Ever had anal intercourse with a man
Drank alcohol in the past 30 days
Sexual Orientation
Circumcised
Genital ulcer in the past 12 months
Casual intercourse in the last 6 months
Ever married
# of lifetime female sexual partners
Age

Values
Yes/No
Yes/No
None/At least once per week
Hetero/ Homo, Bi
Yes/No
Yes/No
Yes/No
Yes/No
Continuous
Continuous

*Decided a priori

Table 2. Descriptive Statistics of serostatus outcome of HIV1, HSV2 for study variables.
Variable
Continuous Median (IQR)
Age
# of lifetime female sexual partners

HSV-, HIV(n=309)

HSV-,HIV+
(n=24)

HSV+,HIV(n=113)

HSV+,HIV+
(n=74)

25 (8)
21 (51)

31 (7)
26 (66)

32 (14)
30 (81)

36 (12)
34 (271)

Total*
(n=520)
28 (12)
25 (71)

Categorical n (%)
Ever used a male condom**
254 (82.7)
22 (91.7)
91 (81.3)
61 (82.4)
428 (82.8)
Ever had anal intercourse with a man**
22 (7.1)
1 (4.2)
9 (8.0)
7 (9.6)
39 (7.5)
Drank alcohol in the past 30 days ***
82 (26.8)
7 (29.2)
41 (36.6)
20 (27.8)
150 (29.2)
Sexual Orientation****
41 (13.6)
1 (4.4)
12 (10.6)
6 (8.2)
60 (11.7)
Casual intercourse in the last 6 months**
209 (68.8)
16 (66.7)
70 (62.5)
38 (52.8)
333 (65.0)
Circumcised**
130 (42.1)
5 (20.8)
49 (43.4)
15 (20.3)
199 (38.3)
Ever married**
110 (35.8)
17 (70.8)
70 (62.5)
57 (78.1)
254 (49.2)
Genital ulcer in the past 12 months**
99 (32.3)
14 (58.3)
48 (42.5)
44 (61.1)
205 (39.7)
*Missing (counts): Ever used a male condom 3, Ever had anal intercourse with a man 2, Drank alcohol in
the past 30 days 6, Sexual Orientation 9, Casual intercourse in the last 6 months 8, Ever married 4,
Genital ulcer in the past twelve months 4
**Category of variable reflecting descriptive statistics is “Yes”
***Category of variable reflecting descriptive statistics is “At least once per week”
****Category of variable reflecting descriptive statistics is “Homo, Bi”
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Table 3. Multiple Logistic Regression Model for HIV1-, HSV2-; model includes 10 independent
variables.
Variable

Level

Adjusted
Odds Ratio

Homo, Bi
Hetero (Reference)

1.27
1.00

At least once per
week
None (Reference)

0.83

0.834

0.510

0.468

1.00

-

-

-

Circumcised

Yes
No (Reference)

1.53
1.00

0.954
-

2.446
-

0.078
-

Ever had anal intercourse with a man

Yes
No (Reference)

1.04
1.00

0.426
-

2.511
-

0.940
-

Ever used a male condom

Yes
No (Reference)

0.98
1.00

0.536
-

1.792
-

0.948
-

Casual intercourse in the last 6 months

Yes
No (Reference)

1.20
1.00

0.751
-

1.907
-

0.451
-

Continuous

1.00

0.997

1.001

0.323

Yes

0.52

0.329

0.809

0.004

No (Reference)

1.00

-

-

-

Yes
No (Reference)

0.52
1.00

0.323
-

0.826
-

0.006
-

Continuous

0.90

0.869

0.932

<.0001

Sexual Orientation

Drank alcohol in the past 30 days

# of lifetime female sexual partner**
Genital ulcer/sore in the past 12
months

Ever married

Age**

*Statistically significant results in bold (α=.05)
** Reference level to continuous variable odds ratios are 1.00
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95% Confidence
Interval
Lower
Upper
0.586
2.771
-

p-value*

0.541
-

Table 4. Multiple Logistic Regression Model for HIV1-, HSV2+; model includes 10 independent
variables.
Variable

Level

Adjusted
Odds Ratio

Homo, Bi
Hetero (Reference)

1.07
1.00

At least once per
week
None (Reference)

1.43

0.850

2.406

0.117

1.00

-

-

-

Circumcised

Yes
No (Reference)

1.35
1.00

0.823
-

2.208
-

0.236
-

Ever had anal intercourse with a man

Yes
No (Reference)

1.04
1.00

0.402
-

2.699
-

0.934
-

Ever used a male condom

Yes
No (Reference)

1.24
1.00

0.633
-

2.415
-

0.534
-

Casual intercourse in the last 6 months

Yes
No (Reference)

1.07
1.00

0.646
-

1.788
-

0.782
-

# of lifetime female sexual partners**

Continuous

1.00

0.998

1.002

0.895

Yes

1.08

0.660

1.759

0.764

No (Reference)

1.00

-

-

-

Yes
No (Reference)

1.38
1.00

0.806
-

2.349
-

0.242
-

Continuous

1.06

1.027

1.094

0.0004

Sexual Orientation

Drank alcohol in the past 30 days

Genital ulcer/sore in the past 12
months

Ever married

Age**

*Statistically significant results in bold (α=.05)
** Reference level to continuous variable odds ratios are 1.00
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95% Confidence
Interval
Lower
Upper
0.471
2.421
-

p-value*

0.874
-

Table 5. Multiple Logistic Regression Model for HIV1+, HSV2-; model includes 10 independent
variables.
Variable

Level

Adjusted
Odds Ratio

Homo, Bi
Hetero (Reference)

0.64
1.00

At least once per
week
None (Reference)

1.03

0.392

2.692

0.956

1.00

-

-

-

Continuous

0.99

0.932

1.052

0.748

Ever had anal intercourse with a man

Yes
No (Reference)

0.55
1.00

0.059
-

5.204
-

0.605
-

Ever used a male condom

Yes
No (Reference)

1.79
1.00

0.395
-

8.136
-

0.449
-

Casual intercourse in the last 6 months

Yes
No (Reference)

0.97
1.00

0.386
-

2.457
-

0.955
-

# of lifetime female sexual partners**

Continuous

1.00

0.995

1.004

0.910

Yes

2.50

0.983

6.192

0.055

No (Reference)

1.00

-

-

-

Ever married

Yes
No (Reference)

2.90
1.00

1.008
-

8.308
-

0.048
-

Circumcised

Yes
No (Reference)

0.26
1.00

0.073
-

0.898
-

0.033
-

Sexual Orientation

Drank alcohol in the past 30 days

Age**

Genital ulcer/sore in the past 12
months

*Statistically significant results in bold (α=.05)
** Reference level to continuous variable odds ratios are 1.00

42

95% Confidence
Interval
Lower
Upper
0.072
5.685
-

p-value*

0.689
-

Table 6. Multiple Logistic Regression Model for HIV1+, HSV2+; model includes 10
independent variables.
Variable

Level

Adjusted
Odds Ratio

Homo, Bi
Hetero (Reference)

0.49
1.00

At least once per
week
None (Reference)

0.99

0.511

1.929

0.983

1.00

-

-

-

Ever Married

Yes
No (Reference)

1.74
1.00

0.855
-

3.548
-

0.126
-

Ever had anal intercourse with a man

Yes
No (Reference)

1.18
1.00

0.354
-

3.899
-

0.793
-

Ever used a male condom

Yes
No (Reference)

0.62
1.00

0.277
-

1.380
-

0.241
-

Casual intercourse in the last 6 months

Yes
No (Reference)

0.66
1.00

0.346
-

1.240
-

0.194
-

# of lifetime female sexual partners**

Continuous

1.00

1.000

1.005

0.042

Yes

2.29

1.217

4.302

0.010

No (Reference)

1.00

-

-

-

Yes
No (Reference)

0.48
1.00

0.234
-

0.954
-

0.037
-

Continuous

1.08

1.041

1.124

<.0001

Sexual Orientation

Drank alcohol in the past 30 days

Genital ulcer/sore in the past 12
months

Circumcised

Age**

*Statistically significant results in bold (α=.05)
** Reference level to continuous variable odds ratios are 1.00
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95% Confidence
Interval
Lower
Upper
0.125
1.886
-

p-value*

0.297
-

Table 7. Comparisons of odds ratios of cross-classified serostatus outcomes in study variables. *Odds ratio ref=1.00, **Level of Categorical Variable
Variable

Cross-Classified Serostatus Odds Ratios*

(HIV1-, HSV2-)

(HIV1-, HSV2+)

(HIV1+, HSV2-)

(HIV1+, HSV2+)

Sexual Orientation
Homo, Bi**

1.27

1.07

0.64

0.49

Drank alcohol in the past 30 days
At least once per week**

0.83

1.43

1.03

0.99

Ever Married
Yes**

0.52

1.38

2.90

1.74

Yes**

1.04

1.04

0.55

1.18

Ever used a male condom
Yes**

0.98

1.24

1.79

0.62

Yes**

1.20

1.07

0.97

0.66

# of lifetime female sexual partners

1.00

1.00

1.00

1.00

Genital ulcer/sore in the past 12
months
Yes**

0.52

1.08

2.50

2.29

Circumcised
Yes**

1.53

1.35

0.26

0.48

Age

0.90

1.06

0.99

1.08

Ever had anal intercourse with a man

Casual intercourse in the last 6 months

44

45

